Merck Beats Sales Estimates Amid Growing Demand for Newer Drugs

Merck & Co. reported first-quarter sales that beat Wall Street estimates as demand ramps up for newer products like Winrevair and an injectable version of cancer blockbuster Keytruda.

View Original Article